| Muskego Health Care Center | |
| S77 W18690 Janesville Rd, Muskego, Wisconsin 53150 | |
| (262) 679-0246 | |
| Name | Muskego Health Care Center |
|---|---|
| Location | S77 W18690 Janesville Rd, Muskego, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 49 |
| Occupancy Rate | 66.33% |
| Medicare ID (CCN) | 525686 |
| Legal Business Name | Muskego Nursing Home Inc. |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1407591274 |
| Organization Name | BAY AT MUSKEGO HEALTH AND REHABILITATION CENTER LLC |
| Doing Business As | MUSKEGO HEALTH AND REHABILITATION CENTER |
| Address | S77w18690 Janesville Rd, Muskego, WI 53150 |
| Phone Number | 262-679-0246 |
News Archive
The National Association For Continence (NAFC) has updated the Male Stress Urinary Incontinence content at www.nafc.org. The new content is designed to be more patient friendly and includes an educational video, as well as additional resources about the diagnosis, treatment, and management of Male Stress Urinary Incontinence.
There has been speculation in the press about the work to be carried out at the planned UK Centre for Medical Research and Innovation, a world-class facility which will deliver ground breaking new research.
The potential effects of climate change on the spread of infectious diseases, such as malaria and dengue fever, are the focus of a nearly $1.9 million grant from the National Science Foundation intended to further the studies of a Penn State-led group of researchers.
CongressDaily reports that Senate Republicans are trying to stop the health care law "one rule at a time." Senate Majority Leader Harry Reid is expected to table the resolution from Sen. Mike Enzi, R-Wyo., regarding the law's "grandfathering" rule, "which allows plans that existed before March 23, 2010 — the date the healthcare law was signed — to be exempt from certain consumer protections enacted in the law, as long as plans do not significantly reduce benefits or raise consumer costs.
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that collaborators from the University of California, San Francisco (UCSF) presented results at the 2014 American Association for Cancer Research (AACR) conference, April 5-9, 2014 in San Diego, CA, highlighting the potential utility of imaging agents derived from Navidea's Manocept™ platform in identifying affected tissues and lymph nodes in patients with Kaposi Sarcoma (KS).
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The National Association For Continence (NAFC) has updated the Male Stress Urinary Incontinence content at www.nafc.org. The new content is designed to be more patient friendly and includes an educational video, as well as additional resources about the diagnosis, treatment, and management of Male Stress Urinary Incontinence.
There has been speculation in the press about the work to be carried out at the planned UK Centre for Medical Research and Innovation, a world-class facility which will deliver ground breaking new research.
The potential effects of climate change on the spread of infectious diseases, such as malaria and dengue fever, are the focus of a nearly $1.9 million grant from the National Science Foundation intended to further the studies of a Penn State-led group of researchers.
CongressDaily reports that Senate Republicans are trying to stop the health care law "one rule at a time." Senate Majority Leader Harry Reid is expected to table the resolution from Sen. Mike Enzi, R-Wyo., regarding the law's "grandfathering" rule, "which allows plans that existed before March 23, 2010 — the date the healthcare law was signed — to be exempt from certain consumer protections enacted in the law, as long as plans do not significantly reduce benefits or raise consumer costs.
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that collaborators from the University of California, San Francisco (UCSF) presented results at the 2014 American Association for Cancer Research (AACR) conference, April 5-9, 2014 in San Diego, CA, highlighting the potential utility of imaging agents derived from Navidea's Manocept™ platform in identifying affected tissues and lymph nodes in patients with Kaposi Sarcoma (KS).
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 2.22 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 11.65 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 37.04 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.14 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.22 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 7.14 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.28 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 8.18 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 87.7 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 4.79 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.35 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 4.9 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.38 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 4.79 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 86.44 | 82.93 |
News Archive
The National Association For Continence (NAFC) has updated the Male Stress Urinary Incontinence content at www.nafc.org. The new content is designed to be more patient friendly and includes an educational video, as well as additional resources about the diagnosis, treatment, and management of Male Stress Urinary Incontinence.
There has been speculation in the press about the work to be carried out at the planned UK Centre for Medical Research and Innovation, a world-class facility which will deliver ground breaking new research.
The potential effects of climate change on the spread of infectious diseases, such as malaria and dengue fever, are the focus of a nearly $1.9 million grant from the National Science Foundation intended to further the studies of a Penn State-led group of researchers.
CongressDaily reports that Senate Republicans are trying to stop the health care law "one rule at a time." Senate Majority Leader Harry Reid is expected to table the resolution from Sen. Mike Enzi, R-Wyo., regarding the law's "grandfathering" rule, "which allows plans that existed before March 23, 2010 — the date the healthcare law was signed — to be exempt from certain consumer protections enacted in the law, as long as plans do not significantly reduce benefits or raise consumer costs.
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that collaborators from the University of California, San Francisco (UCSF) presented results at the 2014 American Association for Cancer Research (AACR) conference, April 5-9, 2014 in San Diego, CA, highlighting the potential utility of imaging agents derived from Navidea's Manocept™ platform in identifying affected tissues and lymph nodes in patients with Kaposi Sarcoma (KS).
› Verified 7 days ago
Tudor Oaks Health Center Location: S77 W12929 Mcshane Dr, Muskego, Wisconsin 53150 Phone: (414) 529-0100 | |
Muskego Health Care Center Location: S77 W18690 Janesville Rd, Muskego, Wisconsin 53150 Phone: (262) 679-0246 |